A Sinner in a Vacuum (SVA)
So... next week shall shed some intriguing light over SVA's just announced today Joint Venture.
They will be 55% owners in a joint venture for a facility that will increase their human vaccine production.
SVA is a rarity in Biotech where they have lots of positive cash flow and little to no debt.
At any time they can tap their recently registered shelf to generate up to $10 million dollars more of money for expansion purposes....of course as I understand it this would be share dillution for investors.... But the impact of SVA expanding their business easily offsets share dillution if they TAP the Shelf Registration because of their need to fund this Joint Venture.
So.... This is simple...This is going to make SVA move from small cap to mid cap when all is said and done.
Hmm.... and people thought H1N1 was the reason to be an SVA investor? .... Think again.
DISCLOSURE: I own 350 shares of SVA.....Yes... I am a sinner in a vacuum... SIN-O-VAC